STELARA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Ustekinumab.
Product ID | 57894-060_17da6982-46cb-4cc7-a05b-12c3370734d1 |
NDC | 57894-060 |
Product Type | Human Prescription Drug |
Proprietary Name | STELARA |
Generic Name | Ustekinumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2009-09-25 |
Marketing Category | BLA / BLA |
Application Number | BLA125261 |
Labeler Name | Janssen Biotech, Inc. |
Substance Name | USTEKINUMAB |
Active Ingredient Strength | 45 mg/.5mL |
Pharm Classes | Interleukin-12 Antagonists [MoA],Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA],Interleukin-12 Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2009-09-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125261 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-09-25 |
Marketing Category | BLA |
Application Number | BLA125261 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-25 |
Marketing Category | BLA |
Application Number | BLA125261 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-25 |
Ingredient | Strength |
---|---|
USTEKINUMAB | 45 mg/.5mL |
SPL SET ID: | c77a9664-e3bb-4023-b400-127aa53bca2b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
57894-054 | Stelara | ustekinumab |
57894-060 | STELARA | ustekinumab |
57894-061 | STELARA | ustekinumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
STELARA 78932838 3791626 Live/Registered |
Johnson & Johnson 2006-07-19 |
STELARA 77725780 4049691 Live/Registered |
JOHNSON & JOHNSON 2009-04-30 |